• Published On : Jul-2018 |
  • Pages : 205 Pages |
  • Format :

Table of Content

1. Executive Summary
    1.1. Market Overview
    1.2. Market Analysis
    1.3. PMR Analysis and Recommendations
    1.4. Wheel of Fortune

2. Market Introduction
    2.1. Market Definition
    2.2. Market Taxonomy

3. Dermatophytic Onychomycosis Therapeutics Market Opportunity Analysis
    3.1. Macro-Economic Factors
    3.2. Opportunity Analysis

4. Market Background
    4.1. List of Growth Hacking Manufacturers
    4.2. Market Dynamics
          4.2.1. Drivers
          4.2.2. Restraints
          4.2.3. Trends
    4.3. Regulatory Scenario

5. Macroeconomic Assumptions

6. Global Economic Outlook
    6.1. Gross Domestic Product by Region & Country, 2006 – 2021
    6.2. Global Healthcare Outlook

7. North America Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2018–2026
    7.1. Introduction
    7.2. Regional Trend
    7.3. Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
          7.3.1. U.S.
          7.3.2. Canada
    7.4. Market Size (US$ Mn) and Forecast By Country, 2018–2026
    7.5. Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2013-2017
          7.5.1. Tablets
                   7.5.1.1. Rx
                   7.5.1.2. OTC
          7.5.2. Nail Paints
                   7.5.2.1. Rx
                   7.5.2.2. OTC
    7.6. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
    7.7. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
          7.7.1. Oral
          7.7.2. Topical
    7.8. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
    7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
          7.9.1. Hospitals
          7.9.2. Clinics
          7.9.3. Independent Pharmacies
          7.9.4. Mail Order Pharmacies
          7.9.5. Drug Stores
    7.10.Market Size (US$ Mn) Forecast By End User, 2018–2026
    7.11.Market Attractiveness Analysis
          7.11.1. By Country
          7.11.2. By Product Type
          7.11.3. By Treatment Type
          7.11.4. By End User
    7.12.Drivers and Restraints: Impact Analysis
    7.13.Key Market Participants – Intensity Mapping

8. Latin America Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2018–2026
    8.1. Introduction
    8.2. Regional Trend
    8.3. Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
          8.3.1. Brazil
          8.3.2. Mexico
          8.3.3. Argentina
          8.3.4. Rest of Latin America
    8.4. Market Size (US$ Mn) and Forecast By Country, 2018–2026
    8.5. Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2013-2017
          8.5.1. Tablets
                   8.5.1.1. Rx
                   8.5.1.2. OTC
          8.5.2. Nail Paints
                   8.5.2.1. Rx
                   8.5.2.2. OTC
    8.6. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
    8.7. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
          8.7.1. Oral
          8.7.2. Topical
    8.8. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
    8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
          8.9.1. Hospitals
          8.9.2. Clinics
          8.9.3. Independent Pharmacies
          8.9.4. Mail Order Pharmacies
          8.9.5. Drug Stores
    8.10.Market Size (US$ Mn) Forecast By End User, 2018–2026
    8.11.Market Attractiveness Analysis
          8.11.1. By Country
          8.11.2. By Product Type
          8.11.3. By Treatment Type
          8.11.4. By End User
    8.12.Drivers and Restraints: Impact Analysis
    8.13.Key Market Participants – Intensity Mapping

9. Europe Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2018–2026
    9.1. Introduction
    9.2. Regional Trend
    9.3. Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K
          9.3.4. Italy
          9.3.5. Spain
          9.3.6. Rest of Europe
    9.4. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
    9.5. Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2013-2017
          9.5.1. Tablets
                   9.5.1.1. Rx
                   9.5.1.2. OTC
          9.5.2. Nail Paints
                   9.5.2.1. Rx
                   9.5.2.2. OTC
    9.6. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
    9.7. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
          9.7.1. Oral
          9.7.2. Topical
    9.8. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
    9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
          9.9.1. Hospitals
          9.9.2. Clinics
          9.9.3. Independent Pharmacies
          9.9.4. Mail Order Pharmacies
          9.9.5. Drug Stores
    9.10.Market Size (US$ Mn) Forecast By End User, 2018–2026
    9.11.Market Attractiveness Analysis
          9.11.1. By Country
          9.11.2. By Product Type
          9.11.3. By Treatment Type
          9.11.4. By End User
    9.12.Drivers and Restraints: Impact Analysis
    9.13.Key Market Participants – Intensity Mapping

10. Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2018–2026
    10.1.Introduction
    10.2.Regional Trend
    10.3.Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
          10.3.1. Japan
          10.3.2. China
          10.3.3. India
          10.3.4. Australia and New Zealand
          10.3.5. Rest of Asia Pacific
    10.4.Market Size (US$ Mn) and Forecast By Country, 2018–2026
    10.5.Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2013-2017
          10.5.1. Tablets
                   10.5.1.1. Rx
                   10.5.1.2. OTC
          10.5.2. Nail Paints
                   10.5.2.1. Rx
                   10.5.2.2. OTC
    10.6.Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
    10.7.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
          10.7.1. Oral
          10.7.2. Topical
    10.8.Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
    10.9.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
          10.9.1. Hospitals
          10.9.2. Clinics
          10.9.3. Independent Pharmacies
          10.9.4. Mail Order Pharmacies
          10.9.5. Drug Stores
    10.10.Market Size (US$ Mn) Forecast By End User, 2018–2026
    10.11.Market Attractiveness Analysis
          10.11.1. By Country
          10.11.2. By Product Type
          10.11.3. By Treatment Type
          10.11.4. By End User
    10.12.Drivers and Restraints: Impact Analysis
    10.13.Key Market Participants – Intensity Mapping

11. Middle East and Africa (MEA) Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2018–2026
    11.1.Introduction
    11.2.Regional Trend
    11.3.Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
          11.3.1. South Africa
          11.3.2. GCC
          11.3.3. Rest of MEA
    11.4.Market Size (US$ Mn) and Forecast By Country, 2018–2026
    11.5.Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2013-2017
          11.5.1. Tablets
                   11.5.1.1. Rx
                   11.5.1.2. OTC
          11.5.2. Nail Paints
                   11.5.2.1. Rx
                   11.5.2.2. OTC
    11.6.Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
    11.7.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
          11.7.1. Oral
          11.7.2. Topical
    11.8.Market Size (US$ Mn) Forecast By Treatment Type, 2018–2026
    11.9.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
          11.9.1. Hospitals
          11.9.2. Clinics
          11.9.3. Independent Pharmacies
          11.9.4. Mail Order Pharmacies
          11.9.5. Drug Stores
    11.10.Market Size (US$ Mn) Forecast By End User, 2018–2026
    11.11.Market Attractiveness Analysis
          11.11.1. By Country
          11.11.2. By Product Type
          11.11.3. By Treatment Type
          11.11.4. By End User
    11.12.Drivers and Restraints: Impact Analysis
    11.13.Key Market Participants – Intensity Mapping

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Competition Analysis
    14.1.Competition Dashboard
    14.2.Company Profiles
          14.2.1. Valeant Pharmaceuticals Inc.
                   14.2.1.1. Overview
                   14.2.1.2. Product and End User Portfolio
                   14.2.1.3. Production Footprint
                   14.2.1.4. Sales Footprint
                   14.2.1.5. Channel Footprint
                   14.2.1.6. Strategy
                               14.2.1.6.1. Marketing Strategy
                               14.2.1.6.2. Product Strategy
                               14.2.1.6.3. Channel Strategy
          14.2.2. Galderma S.A.
                   14.2.2.1. Overview
                   14.2.2.2. Product and End User Portfolio
                   14.2.2.3. Production Footprint
                   14.2.2.4. Sales Footprint
                   14.2.2.5. Channel Footprint
                   14.2.2.6. Strategy
                               14.2.2.6.1. Marketing Strategy
                               14.2.2.6.2. Product Strategy
                               14.2.2.6.3. Channel Strategy
          14.2.3. Novartis AG
                   14.2.3.1. Overview
                   14.2.3.2. Product and End User Portfolio
                   14.2.3.3. Production Footprint
                   14.2.3.4. Sales Footprint
                   14.2.3.5. Channel Footprint
                   14.2.3.6. Strategy
                               14.2.3.6.1. Marketing Strategy
                               14.2.3.6.2. Product Strategy
                               14.2.3.6.3. Channel Strategy
          14.2.4. Pfizer, Inc.
                   14.2.4.1. Overview
                   14.2.4.2. Product and End User Portfolio
                   14.2.4.3. Production Footprint
                   14.2.4.4. Sales Footprint
                   14.2.4.5. Channel Footprint
                   14.2.4.6. Strategy
                               14.2.4.6.1. Marketing Strategy
                               14.2.4.6.2. Product Strategy
                               14.2.4.6.3. Channel Strategy
          14.2.5. Moberg Pharma AB
                   14.2.5.1. Overview
                   14.2.5.2. Product and End User Portfolio
                   14.2.5.3. Production Footprint
                   14.2.5.4. Sales Footprint
                   14.2.5.5. Channel Footprint
                   14.2.5.6. Strategy
                               14.2.5.6.1. Marketing Strategy
                               14.2.5.6.2. Product Strategy
                               14.2.5.6.3. Channel Strategy
          14.2.6. Johnson & Johnson Services, Inc.
          14.2.6. Overview
                   14.2.6.2. Product and End User Portfolio
                   14.2.6.3. Production Footprint
                   14.2.6.4. Sales Footprint
                   14.2.6.5. Channel Footprint
                   14.2.6.6. Strategy
                               14.2.6.6.1. Marketing Strategy
                               14.2.6.6.2. Product Strategy
                               14.2.6.6.3. Channel Strategy
          14.2.7. Bayer AG
                   14.2.7.1. Overview
                   14.2.7.2. Product and End User Portfolio
                   14.2.7.3. Production Footprint
                   14.2.7.4. Sales Footprint
                   14.2.7.5. Channel Footprint
                   14.2.7.6. Strategy
                               14.2.7.6.1. Marketing Strategy
                               14.2.7.6.2. Product Strategy
                               14.2.7.6.3. Channel Strategy
          14.2.8. Dr. Reddy’s Laboratories Ltd.
                   14.2.8.1. Overview
                   14.2.8.2. Product and End User Portfolio
                   14.2.8.3. Production Footprint
                   14.2.8.4. Sales Footprint
                   14.2.8.5. Channel Footprint
                               14.2.8.6.1. Strategy
                               14.2.8.6.1. Marketing Strategy
                               14.2.8.6.2. Product Strategy
                               14.2.8.6.3. Channel Strategy
          14.2.9. Cipla Ltd.
                   14.2.9.1. Overview
                   14.2.9.2. Product and End User Portfolio
                   14.2.9.3. Production Footprint
                   14.2.9.4. Sales Footprint
                   14.2.9.5. Channel Footprint
                               14.2.9.5.1. Strategy Marketing Strategy
                               14.2.9.5.2. Product Strategy
                               14.2.9.5.3. Channel Strategy
          14.2.10. Medimetriks Pharmaceuticals, Inc.
                   14.2.10.1. Overview
                   14.2.10.2. Product and End User Portfolio
                   14.2.10.3. Production Footprint
                   14.2.10.4. Sales Footprint
                   14.2.10.5. Channel Footprint
                               14.2.10.5.1. Strategy Marketing Strategy
                               14.2.10.5.2. Product Strategy
                               14.2.10.5.3. Channel Strategy

15. Global Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2017–2026, By Region
    15.1.Introduction/Key Findings
    15.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2013-2017
    15.3.Market Size (US$ Mn) Forecast By Region, 2017–2026
          15.3.1. North America
          15.3.2. Latin America
          15.3.3. Europe
          15.3.4. Asia Pacific
          15.3.5. Middle East & Africa
    15.4.Market Attractiveness Analysis By Region

16. Global Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2017–2026, By Product Type
    16.1.Introduction/Key Findings
    16.2.Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2013-2017
          16.2.1. Tablets
                   16.2.1.1. Rx
                   16.2.1.2. OTC
          16.2.2. Nail Paints
                   16.2.2.1. Rx
                   16.2.2.2. OTC
    16.3.Market Size (US$ Mn) and Forecast By Product Type, 2017–2026
    16.4.Market Attractiveness Analysis By Product Type

17. Global Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017 and Forecast 2017–2026, By Treatment Type
    17.1.Introduction/Key Findings
    17.2.Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013-2017
          17.2.1. Oral
          17.2.2. Topical
    17.3.Market Size (US$ Mn) Forecast By Treatment Type, 2017–2026
    17.4.Market Attractiveness Analysis By Treatment Type

18. Global Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017and Forecast 2017–2026, By End User
    18.1.Introduction/Key Findings
    18.2.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017
          18.2.1. Hospitals
          18.2.2. Clinics
          18.2.3. Independent Pharmacies
          18.2.4. Mail Order Pharmacies
          18.2.5. Drug Stores
    18.3.Market Size (US$ Mn) Forecast By End User, 2017–2026
    18.4.Market Attractiveness Analysis By End User

19. Global Dermatophytic Onychomycosis Therapeutics Market Analysis 2013-2017and Forecast 2017–2026
    19.1.Market Value Share Analysis By All Segment
    19.2.Y-o-Y Growth Analysis By All Segment
    19.3.Absolute $ Opportunity

20. Research Methodology


List of Table

Table 01: North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 02: North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Product Type
Table 03: North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 04: North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 05: North America Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
Table 06: Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 07: Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Product Type
Table 08: Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 09: Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 10: Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 11: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
Table 12: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 13: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Product Type
Table 14: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 15: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 16: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
Table 17: Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 18: Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Product Type
Table 19: Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 20: Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 21: Latin America Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
Table 22: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Product Type
Table 24: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 25: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 26: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
Table 27: Global Dermatophytic Onychomycosis Therapeutic products Size (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region, 
Table 28: Global Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Product Type
Table 29: Global Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Treatment Type
Table 30: Global Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel


List of Figures

Figure 01: North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2018E)
Figure 02: North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2018E)
Figure 03: North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2018E)
Figure 04: North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2018E)
Figure 05: North America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 06: North America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 07: U.S. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 08: U.S. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 09: Canada Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 10: Canada Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 11: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2018–2026
Figure 12: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2018–2026
Figure 13: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 14: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2018–2026
Figure 15: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2018E)
Figure 16: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2018E)
Figure 17: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2018E)
Figure 18: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2018E)
Figure 19: Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 20: Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 21: Germany Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 22: Germany Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 23: France Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 24: France Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 25: U.K. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 26: U.K. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 27: Italy Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 28: Italy Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 29: Spain Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 30: Spain Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 31: Rest of Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 32: Rest of Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 33: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2018–2026
Figure 34: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2018–2026
Figure 35: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 36: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2018–2026
Figure 37: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2018E)
Figure 38: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2018E)
Figure 39: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2018E)
Figure 40: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2018E)
Figure 41: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 42: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 43: Japan Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 44: Japan Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 45: China Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 46: China Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 47: India Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 48: India Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 49: ANZ Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 50: ANZ Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 51: Rest of APAC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 52: Rest of APAC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 53: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2018–2026
Figure 54: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2018–2026
Figure 55: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 56: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2018–2026
Figure 57: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2018E)
Figure 58: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2018E)
Figure 59: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2018E)
Figure 60: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2018E)
Figure 61: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 62: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 63: Brazil Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 64: Brazil Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 65: Mexico Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 66: Mexico Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 67: Argentina Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 68: Argentina Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 69: Rest of LAM Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 70: Rest of LAM Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 71: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2018–2026
Figure 72: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2018–2026
Figure 73: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 74: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2018–2026
Figure 75: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2018E)
Figure 76: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2018E)
Figure 77: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2018E)
Figure 78: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2018E)
Figure 79: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 80: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 81: GCC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 82: GCC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 83: South Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 84: South Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 85: Rest of MEA Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 86: Rest of MEA Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 87: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2018–2026
Figure 88: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2018–2026
Figure 89: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 90: Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2018–2026
Figure 91: Global Lithotripsy Devices  Share Analysis (%), By Region, 2018 & 2026
Figure 92: Global Lithotripsy Devices  Y-o-Y Analysis (%), By Region, 2018-2026
Figure 93: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Region, 2018–2026
Figure 94: Global Lithotripsy Device Market Share Analysis (%), By Product Type, 2018 & 2026
Figure 95: Global Lithotripsy Device Market Y-o-Y Analysis (%), By Product Type, 2018-2026
Figure 96: Tablets Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 97: Tablets Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 98: Nail Paints Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 99: Nail Paints Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 100: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2018–2026
Figure 101: Global Lithotripsy Device Market Share Analysis (%), By Product Type, 2018 & 2026
Figure 102: Global Lithotripsy Device Market Y-o-Y Analysis (%), By Product Type, 2018-2026
Figure 103:  Oral Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 104: Oral Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 105: Topical Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 106: Topical Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 107: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2018–2026
Figure 108: Global Dermatophytic Onychomycosis Therapeutics Market Share Analysis (%), By Distribution Channel, 2018 & 2026
Figure 109: Global Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2026
Figure 110: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2018–2026
Figure 111: Global Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2013–2017
Figure 112: Global Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2018-2026
Figure 113: Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity, 2018-2026